Phoebe Mounts
Keine laufenden Positionen mehr
Vermögen: 37 368 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Phoebe Mounts
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 15 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Phoebe Mounts
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Amneal Pharmaceuticals LLC
 Amneal Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Amneal Pharmaceuticals LLC manufactures and distributes generic pharmaceuticals. It offers buprenorphine and naloxone tablets, ear drops, scalp and body oils, liquid syrups, folic acid tablets and oral solids. The company was founded by Chintu Patel, Chirag K. Patel and Jiten Parikh in June 2002 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| UCB Pharma AB | Chairman | ||
Da Volterra SA
 Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | Biotechnology | Chairman | |
| PROCESSA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Cranfield School of Management | College/University | Masters Business Admin | |
| UCB AE | Chairman | ||
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| UCB Pharma Sp zoo | Chief Executive Officer | ||
| City University London | College/University | Undergraduate Degree | |
UCB Pharma Ltd.
 UCB Pharma Ltd. Pharmaceuticals: MajorHealth Technology UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| UCB Pharma AS | Chairman | ||
Vedim Pharma SA
 Vedim Pharma SA Pharmaceuticals: MajorHealth Technology Part of UCB SA, Vedim Pharma SA is a French pharmaceutical company that manufactures pharmaceuticals. | Pharmaceuticals: Major | Corporate Officer/Principal | |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Financial Conglomerates | Director/Board Member | |
UCB Pharma SA
 UCB Pharma SA Chemicals: SpecialtyProcess Industries UCB Pharma SA manufactures pharmaceutical products. It develops products in areas, such as epilepsy, central nervous system, immunology and inflammation. The company is headquartered in Molins de Rei, Spain | Chemicals: Specialty | Corporate Officer/Principal | |
| Juvenile Diabetes Research Foundation of Arizona, Inc. | Director/Board Member | ||
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| POXEL | Pharmaceuticals: Major | Chairman | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing | |
| Biotie Therapeutics Corp. | Director/Board Member | ||
| Southeast BIO | Director/Board Member | ||
| VIRIOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| LONGEVERON INC. | Biotechnology | Director/Board Member | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| American Psychiatric Foundation | Director/Board Member | ||
IWH UK Holdco Ltd.
 IWH UK Holdco Ltd. Miscellaneous Commercial ServicesCommercial Services IWH UK Holdco Ltd. is a private company that provides business services. The company is based in London, UK. The British company was founded in 2017. | Miscellaneous Commercial Services | Director/Board Member | |
| New York University School of Law | College/University | Graduate Degree | |
Akorn Operating Co. LLC
 Akorn Operating Co. LLC Pharmaceuticals: MajorHealth Technology Akorn Operating Co. LLC operates as a specialty generic pharmaceutical manufacturing company. It focuses on generic drugs in alternate dosage forms such as ophthalmic drugs, injectable drugs and others in liquid, semi-solid, topical and nasal spray dosage forms. The company is headquartered in Lake Forest, IL. | Pharmaceuticals: Major | Chief Administrative Officer | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Corporate Officer/Principal | |
| Dartmouth College | College/University | Undergraduate Degree | |
| New York University School of Medicine | College/University | Doctorate Degree | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Pepperdine University | College/University | Masters Business Admin | |
| Eckerd College | College/University | Undergraduate Degree | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | General Counsel | |
| OPKO HEALTH, INC. | Medical/Nursing Services | Corporate Officer/Principal | |
| Theramex Italy Srl | Chief Executive Officer | ||
Iwh Uk Investco Ltd.
 Iwh Uk Investco Ltd. Medical DistributorsDistribution Services IWH UK Investco Ltd. is a pharmaceutical and medical products wholesaler based in London, UK. IWH UK Investco specializes in the distribution of pharmaceutical and medical products. The British company was founded in 2017. | Medical Distributors | Director/Board Member | |
| Fairleigh Dickinson University | College/University | Director/Board Member | |
IWH UK Finco Ltd.
 IWH UK Finco Ltd. Financial ConglomeratesFinance IWH UK Finco Ltd. functions as an investment holding private company. The company is based in London, UK. and has subsidiaries in United Kingdom. | Financial Conglomerates | Director/Board Member | |
IWH UK Midco Ltd.
 IWH UK Midco Ltd. Financial ConglomeratesFinance IWH UK Midco Ltd. operates as an investment holding firm. The company was founded on September 4, 2017 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Theramex HQ UK Ltd.
 Theramex HQ UK Ltd. Pharmaceuticals: MajorHealth Technology Theramex HQ UK Ltd. operates as a international pharmaceutical company that provides healthcare solutions for women. The company was founded in 1970 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
| CIPLA LIMITED | Pharmaceuticals: Other | Director/Board Member | |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
National Association of Manufacturers
 National Association of Manufacturers Miscellaneous Commercial ServicesCommercial Services The National Association of Manufacturers is an organization that works for the success of over 12.9 million people who are involved in manufacturing. The non-profit company is based in Washington and has subsidiaries in the United States. The American company's work is based on four core values that drive the industry. The company commissioned a study in August 2015, which found that the EPA's proposed ozone rule could reduce GDP by $140 billion. The CEO of the company is Jay Timmons. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 31 |
| Vereinigtes Königreich | 9 |
| Frankreich | 4 |
| Belgien | 2 |
| Schweden | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Finance | 4 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 39 |
| Corporate Officer/Principal | 35 |
| Chief Executive Officer | 16 |
| President | 15 |
| Undergraduate Degree | 10 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Robert Stewart | 20 |
| Mohammed Khoso Baluch | 19 |
| Mehmood Khan | 18 |
| Gregory Duncan | 12 |
| John L. Armstrong | 11 |
| Bob Cook | 11 |
| Paulo Costa | 11 |
| Joseph Todisco | 7 |
| Thomas Nusbickel | 5 |
| Mathew David | 4 |
| Beth Zelnick Kaufman | 4 |
| Donna Ucci | 2 |
| Erin Mistry | 2 |
| Frank Raffaele | 1 |
| Tushar Mukherjee | 1 |
- Börse
- Insiders
- Phoebe Mounts
- Unternehmensverbindungen
